Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011, Article ID 397646, 3 pages
http://dx.doi.org/10.1155/2011/397646
Case Report

Tophaceous Gout and Renal Insufficiency: A New Solution for an Old Therapeutic Dilemma

1Section of Rheumatology, Department of Internal Medicine, University Clinic “Carl Gustav Carus” of the Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
2Department of Cardiology and Intensive Care, Heart Centre Dresden, University Hospital of the Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany

Received 24 February 2011; Accepted 12 March 2011

Academic Editor: P. E. Schwarz

Copyright © 2011 Anne-Kathrin Tausche et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Dalbeth and D. O. Haskard, “Inflammation and tissue damage in crystal deposition diseases,” Current Opinion in Rheumatology, vol. 17, no. 3, pp. 314–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Annemans, E. Spaepen, M. Gaskin et al., “Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005,” Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 960–966, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. D. H. Kang and T. Nakagawa, “Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease,” Seminars in Nephrology, vol. 25, no. 1, pp. 43–49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. L. Wortmann, “The management of gout: it should be crystal clear,” Journal of Rheumatology, vol. 33, no. 10, pp. 1921–1922, 2006. View at Google Scholar · View at Scopus
  5. W. Zhang, M. Doherty, T. Bardin et al., “EULAR evidence based recommendations for gout—part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT),” Annals of the Rheumatic Diseases, vol. 65, no. 10, pp. 1312–1324, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. A. Sarawate, K. K. Brewer, W. Yang et al., “Gout medication treatment patterns and adherence to standards of care from a managed care perspective,” Mayo Clinic Proceedings, vol. 81, no. 7, pp. 925–934, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. K. R. Hande, R. M. Noone, and W. J. Stone, “Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency,” American Journal of Medicine, vol. 76, no. 1, pp. 47–56, 1984. View at Google Scholar · View at Scopus
  8. A. K. Tausche, M. Aringer, H. E. Schroeder, S. R. Bornstein, C. Wunderlich, and G. Wozel, “The janus faces of allopurinol-allopurinol hypersensitivity syndrome,” American Journal of Medicine, vol. 121, no. 3, pp. e3–e4, 2008. View at Publisher · View at Google Scholar · View at PubMed
  9. M. A. Becker, H. R. Schumacher Jr., R. L. Wortmann et al., “Febuxostat compared with allopurinol in patients with hyperuricemia and gout,” New England Journal of Medicine, vol. 353, no. 23, pp. 2450–2461, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. A. Whelton, P. A. MacDonald, L. Zhao, B. Hunt, and L. Gunawardhana, “Renal function in gout: long-term treatment effects of febuxostat,” Journal of Clinical Rheumatology, vol. 17, no. 1, pp. 7–13, 2011. View at Publisher · View at Google Scholar · View at PubMed
  11. T. L. Jansen, P. Richette, F. Perez-Ruiz et al., “International position paper on febuxostat,” Clinical Rheumatology, vol. 29, no. 8, pp. 835–840, 2010. View at Publisher · View at Google Scholar · View at PubMed
  12. W. Urano, H. Yamanaka, H. Tsutani et al., “The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis,” Journal of Rheumatology, vol. 29, no. 9, pp. 1950–1953, 2002. View at Google Scholar · View at Scopus
  13. A. K. Tausche, T. L. Jansen, H. E. Schröder, S. R. Bornstein, M. Aringer, and U. Müller-Ladner, “Gout—current diagnosis and treatment,” Deutsches Aerzteblatt International, vol. 106, no. 34-35, pp. 549–555, 2009. View at Publisher · View at Google Scholar · View at PubMed